BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 18, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Gilead Sciences divulges new IKZF2 degradation inducers for treatment of cancer
To read the full story,
subscribe
or
sign in
.
Cancer
Gilead Sciences divulges new IKZF2 degradation inducers for treatment of cancer
Oct. 13, 2023
No Comments
Molecular glues acting as zinc finger protein Helios (IKZF2) degradation inducers are described in a Gilead Sciences Inc. patent and reported to be useful for the treatment of cancer.
BioWorld Science
Cancer
Patents